/PRNewswire/ Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies.
A 29-year-old man is being referred to as a baby-man because he has a rare illness which prevented him from growing. He known as Pingping, has a medical cond